Breast, bowel and lung cancer Flashcards
Classifications of breast cancer
Ductal carcinoma in situ
Lobular carcinoma in situ
Invasive ductal carcinoma
Invasive lobular carcinoma
Genetic associations with breast cancer
BRCA1, BRCA2
HER2
TP53
PTEN
Risk factors of breast cancer
Family history
Hx of ovarian/ endometrial
Combined HRT
Smoking
Increased oestrogen exposure: obesity, early menarches, late menopause
First line investigations for breast cancer
Triple assessment
- Mammogram
- Fine need biopsy and histology
- Lymph node biopsy
What receptors are screened for in breast cancer
Oestrogen receptor
Progesterone receptor
HER2
__________ tend to be detected on mammograms by forming microcalfications
ductal carcinoma
Examples of benign breast tumours
Fibroadenoma
Adenoma
Papilloma
Lipoma
Breast cancer screening starts from age _____ and occurs every _____ years until age ____
Age 50, every 3 years until age 70
Family history High risk factors for breast cancer
1st degree relative affected <40 or bilateral <50.
1st degree male affected
Two 1st degree relatives affected.
Patients with high risk family history for breast cancer are….
Offered annual mammograms
Given chemoprevention/ can have surgery
Chemoprevention for breast cancer
Tamoxifen (for premenopausal)
Anastrozole (post-menopausal)
2-week referral indications for breast cancer
Unexplained breast/ axillary lump in age >30
Unilateral nipple changes in age >50
Breast cancer skin changes
_________ index is used for staging breast cancer
Nottingham prognostic index
______ is the therapy used to target HER2 in breast cancer
Herceptin
_______ is the therapy used to target oestrogen-receptor positive breast cancer
Tamoxifen (pre-menopausal)
Anastrozole (post-menopausal)
______ is a labelling protein used for breast cancer that is associated with proliferation
Ki67